1. Borota L, Marinkovic S, Bajic R, Kovacevic M. Intracranial aneurysms associated with Moyamoya disease. Neurol Med Chir (Tokyo). 1996; Dec. 36(12):860–4.
2. Coughlin DJ, Miller CA, Schuette AJ. Treatment of Moyamoya disease and unruptured intracranial aneurysm in floatingharbor syndrome. World Neurosurg. 2017; Aug. 104:1049.
3. Teixeira BCA, Cardoso-Demartini AA. Choreoathetosis in Moyamoya disease. World Neurosurg. 2021; Dec. 156:103–4.
4. Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke. 2012; Jan. 43(1):56–60.
5. Kim JH, Kwon TH, Kim JH, Chong K, Yoon W. Intracranial aneurysms in adult Moyamoya disease. World Neurosurg. 2018; Jan. 109:e175–82.
6. Kim S, Jang CK, Park EK, Shim KW, Kim DS, Chung J, et al. Clinical features and outcomes of intracranial aneurysm associated with Moyamoya disease. J Clin Neurol. 2020; Oct. 16(4):624–32.
7. Lee CY. Embolization with NBCA for ruptured aneurysm located in the Moyamoya-like collateral network associated with isolated middle cerebral artery occlusion. Asian J Neurosurg. 2018; Oct-Dec. 13(4):1236–8.
8. Matsushima Y, Qian L, Aoyagi M. Clin Neurol Neurosurg. Asian J Neurosurg. 1997; Oct. 99 Suppl 2:S19–22.
9. Takahashi JC, Miyamoto S. Moyamoya disease: recent progress and outlook. Neurol Med Chir (Tokyo). 2010; 50(9):824–32.
10. Yamada H, Saga I, Kojima A, Horiguchi T. Short-term spontaneous resolution of ruptured peripheral aneurysm in Moyamoya disease. World Neurosurg. 2019; Jun. 126:247–51.
11. Zhang L, Xu K, Zhang Y, Wang X, Yu J. Treatment strategies for aneurysms associated with Moyamoya disease. Int J Med Sci. 2015; Feb. 12(3):234–42.
12. Zhao X, Wang X, Wang M, Meng Q, Wang C. Treatment strategies of ruptured intracranial aneurysms associated with Moyamoya disease. Br J Neurosurg. 2021; Apr. 35(2):209–15.